Findings presented today at Digestive Disease Week 2007, from long-term extensions of the ACT trials show that subjects with moderately to severely active ulcerative colitis who had responded to REMICADE in the blinded phase of the trials maintained improvement in their clinical symptoms for up to ...
By analogy to the efficacy of TNF-α antagonists in the treatment of generalized pustular psoriasis, our patient illustrates the long-term efficacy and safety of etanercept (Enbrel®) in the treatment of Hallopeau’s acrodermatitis refractory to infliximab (Remicade®). This treatment alternative...
Thus, we aimed to investigate the clinical manifestations, laboratory findings, treatment, and long-term outcomes in patients with childhood-onset PAN and to evaluate the usefulness of the paediatric vasculitis activity score (PVAS). We retrospectively analysed the data of nine patients with childhood...
Infliximab (Remicade) can be used in Scotland for treatment of paediatric patients with severe active Crohn's disease, the Scottish Medicines Consortium has decided in its latest round of appraisals. Patients aged six to 17 years who hav... The Pharmaceutical Journal Group - 《Pharmaceutical Journa...
A chimeric antibody (Remicade™) has been developed to bind specifically to human tumor necrosis factor alpha (TNFα) for the short-term treatment of Crohn's. This antibody is indicated for the reduction of the symptoms of moderate to severe Crohn's disease in patients who have had an inad...
Long-term clinical outcomes after switching from Remicade((R)) to biosimilar CT-P13 in inflam- matory bowel disease. Dig Dis Sci 2017;62:3117-22.Smits LJT, Grelack A, Derikx L, et al. Long-Term Clinical Outcomes After Switching from Remicade((R)) to Biosimilar CT-P13 in Inflammatory ...
OBJECTIVES: Infliximab (Remicade) (I) 5mg/kg is effective to control refractory Crohn's disease in 81% and to improve fistulas in 68% of patients, thus greatly improving quality of life (QoL). The objective of this study was to calculate the direct costs and savings generated by I to ...
Patients with active ulcerative colitis who respond to infliximab [Remicade] maintain long-term clinical improvement
AIMS. The objective of this analysis was to determine the long-term retention patterns of stable Canadian IBD patients treated with REMICADE (infliximab [IFX]). METHODS. Using IMS Brogan Canadian private and public insurance claims data, our analysis included IBD patients with: (1) first IFX ...
Infliximab for the treatment of refractory noninfectious Uveitis: a study of 88 patients with long-term follow-up. Ophthalmology. 2014;121(1):358-64. This is the largest retospective study examined the efficacy of infliximab for the treatment of refractory non-infectious uveitis....